PITTSBURGH - November 21, 2007 - The Bayer Foundation today announced it will award a total of $1.5 million in grants over the next few years to a number of nonprofit organizations and universities ...

The MarketWatch News Department was not involved in the creation of this content. GENEVA and BERLIN, Oct. 14, 2025 /PRNewswire/ -- The WHO Foundation today announced a wide-ranging collaboration with ...

Reaffirming its commitment to the greater Raleigh-Durham area, Bayer CropScience today announced increased support of Passage Home, the Raleigh-based anti-poverty organization whose programs have been ...

LEVERKUSEN, Germany, Sept. 9, 2025 /PRNewswire/ -- The Bayer Foundation Women Entrepreneurs Award (BFWEA), powered by the Impact Hub Network, honours 15 women from Latin America, Africa & the Middle ...

Bayer Foundation has published its 2022 report highlighting its activities to strengthen scientific capacities and social entrepreneurship around the world together with its partners. Among other ...

FRANKFURT (Reuters) - Bayer announced a collaboration deal with Roche's Foundation Medicine Inc. to develop a test for sequencing tumour genomes to identify patients who can benefit from Bayer's ...

Bayer Foundation and the Pula Foundation have announced at World Economic Forum that they are planning to provide insurance coverage for 10 million smallholder farmers In Nigeria and other parts of ...

WHIPPANY, N.J.--(BUSINESS WIRE)--For the sixth consecutive year, Bayer U.S. received a score of 100 on the Human Rights Campaign Foundation’s 2023-2024 Corporate Equality Index (CEI), the nation’s ...

Foundation Medicine has nabbed a U.S. green light as the only companion diagnostic for Bayer’s Vitrakvi (larotrectinib). The FoundationOne CDx genomic test is now available to seek out patients who ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced that the U.S. Food and Drug Administration (FDA) approved FoundationOne ® CDx for use as the first companion diagnostic to help identify neurotrophic ...

Bayer has teamed up with Foundation Medicine to develop genetic diagnostic tests for several of its cancer therapies—starting with the tissue-agnostic Vitrakvi in solid tumors with TRK fusion ...

GENEVA and BERLIN, Oct. 14, 2025 /PRNewswire/ -- The WHO Foundation today announced a wide-ranging collaboration with Bayer to support global health initiatives. The agreement will help to resource ...